Papers matching “pegylated interferon-alpha” 16
Not finding it? Sign in to also search OpenAlex live.
-
Clinicohematologic and Molecular Response of Essential Thrombocythemia Patients Treated with Pegylated Interferon-Alpha: A Multicenter Study on Behalf of the German Study Group-MPN (GSG-MPN)
Frank Stegelmann, Lino Lars Teichmann, Florian Heinrich Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, +11 more
0citations -
Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection2023 Acta Dermato Venereologica article Medicine Cutaneous lymphoproliferative disorders research Open access
Janika Gosmann, Rudolf Stadler, Koen D. Quint, Ralf Gutzmer, Maarten H. Vermeer
17citations -
Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial
Monique K. van der Kooij, Els M.E. Verdegaal, Marten Visser, Linda de Bruin, Caroline E. van der Minne, Pauline Meij, +7 more
11citations -
356 Personalized immunotherapy by adoptive T cell transfer during chemotherapy with or without interferon-alpha in patients with recurrent platinum-sensitive epithelial ovarian cancer2021 Regular and Young Investigator Award Abstracts conference-abstract Medicine Ovarian cancer diagnosis and treatment Open access
Els M.E. Verdegaal, Marten Visser, Lien van der Minne, Linda de Bruin, Inge C.F.M. Roozen, Pauline Meij, +2 more
0citations -
Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)
Frank Stegelmann, Lino Lars Teichmann, Florian Heinrich Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, +11 more
8citations -
Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group
Andreas Burchert, Susanne Saußele, Stephan Metzelder, Andreas Hochhaus, Norbert Gattermann, Martina Margrit Crysandt, +27 more
13citations -
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology2020 Journal of General Virology article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 17 patents
Natacha S. Ogando, Tim J. Dalebout, Jessika C. Zevenhoven-Dobbe, Ronald W.A.L. Limpens, Leon Caly, Julian D Druce, +5 more
557citations -
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology2020 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 17 patents
Natacha S. Ogando, Tim J. Dalebout, Jessika C. Zevenhoven-Dobbe, Ronald W.A.L. Limpens, Leon Caly, Julian D Druce, +5 more
70citations -
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 20232023 European Journal of Cancer article Medicine Cutaneous lymphoproliferative disorders research Open access
Johanna Latzka, Chalid Assaf, Martine Bagot, Antonio Cozzio, Reinhard Dummer, Emmanuella Guenova, +20 more
189citations -
Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways2025 medRxiv preprint Biochemistry, Genetics and Molecular Biology Genetic Associations and Epidemiology Open access
Marijana Vujković, David Edward Kaplan, Jonas Ghouse, Bao‐Li Loza, Joseph Brancale, Michael G. Levin, +55 more
1citations -
Inhibition of JAK2V617F-Driven Neoplastic Endothelial Dysfunction by IFNα as a Novel Antifibrotic Mechanism2024 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment
Madeline J. Caduc, Mohamed H. Elsafi Mabrouk, Martin Graßhoff, Dickson W.L. Wong, Cristina Baquero López, Eva Miriam Buhl, +13 more
1citations -
Ropeginterferon alfa-2b in essential thrombocythemia of all risk levels ineligible for standard cytoreduction: 12-month primary endpoint analysis from the ROP-ET phase 3 study2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Jean‐Jacques Kiladjian, Alberto Álvarez‐Larrán, Konstanze Döhner
2citations
16 results